LIPO ESCULTURA capsules, 250 mg, 60-count bottles, Distributed By: JAT Productos Naturales Corp., BROOKLYN, NY 11238, www.lipoesculturatreatment.com
Published June 1, 2016 · Recall initiated: December 3, 2015
Summary
FDA records drug Class I recall D-0860-2016, published June 1, 2016 and initiated December 3, 2015. Recalling firm: Lipo Escultura Corp.; Status: Terminated; Reported quantity: unknown; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, and diclofenac, a prescription non-steroidal anti-inflammatory drug, making this an unapproved drug.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Lipo Escultura Corp.
- Distributor
- Nationwide via Internet sales
- Lot
- All lots
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAmikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: TevaJune 1, 2016
- FDA0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, RxJune 1, 2016
- FDASclerosol Intrapleural Aerosol (sterile talc powder), Intrapleural administration, 4 g Canister, Rx Only,June 1, 2016
- FDA0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, RxJune 1, 2016
- FDAMetronidazole Injection USP, 500 mg per 100 mL (5 mg/mL), 100mL Sterile Single Dose Container bag, Rx only,June 1, 2016
- FDACustom Paks containing 23G and 25G valved trocar cannula provide access into the posterior segment of the eyeMay 25, 2016
Questions about this recall
Was LIPO ESCULTURA capsules, 250 mg, 60-count bottles, Distributed By: JAT Productos Naturales Corp., BROOKLYN, NY 11238, www.lipoesculturatreatment.com recalled?
Yes. FDA published recall D-0860-2016 on June 1, 2016. Reported hazard: Marketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, and diclofenac, a prescription non-steroidal anti-inflammatory drug, making this an unapproved drug.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release